4-(methylthio)-3-butenyl isothiocyanate has been researched along with Esophageal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akagi, JI; Cho, YM; Hirata, T; Nakamura, Y; Numazawa, S; Ogawa, K; Suzuki, I; Toyoda, T | 1 |
1 other study(ies) available for 4-(methylthio)-3-butenyl isothiocyanate and Esophageal Neoplasms
Article | Year |
---|---|
4-Methylthio-3-butenyl isothiocyanate (MTBITC) induced apoptotic cell death and G2/M cell cycle arrest via ROS production in human esophageal epithelial cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Epithelial Cells; Esophageal Neoplasms; G2 Phase Cell Cycle Checkpoints; Humans; Isothiocyanates | 2019 |